During Monday’s Current trade, Shares of Broadcom Corporation (NASDAQ:BRCM), gain 0.34% to $50.67.
Broadcom Corporation (BRCM), a global innovation leader in semiconductor solutions for wired and wireless communications, recently declared it will pay its next quarterly cash dividend of $0.14 per share to holders of the Company’s common stock.
The $0.14 dividend was declared by the Board of Directors on August 13, 2015 and will be paid on September 14, 2015 to holders of record of the Company’s Class A and Class B common stock at the close of business on August 28, 2015.
Broadcom Corporation provides semiconductor solutions for wired and wireless communications. Its products offer voice, video, data, and multimedia connectivity in the home, office, and mobile environments. The company operates in two segments: Broadband and Connectivity, and Infrastructure and Networking. The Broadband and Connectivity segment offers platform solutions for cable, satellite, Internet protocol, over-the-top, and terrestrial set-top boxes; DSL, cable, and fiber broadband access services; femtocell to enhance cellular coverage and small cell low-powered radio access nodes, in addition to location-based services technology and touch controllers; and integrated and discrete Wi-Fi, bluetooth, and near field communication solutions.
Shares of Relypsa Inc (NASDAQ:RLYP), declined -1.89% to $24.42, during its current trading session.
Relypsa, Inc. (RLYP), a biopharmaceutical company, recently stated financial results for the quarter ended June 30, 2015. Net loss for the second quarter 2015 was $39.3 million, or $0.95 per share, contrast to $16.7 million, or $0.51 per share, for the comparable period in 2014.
Cash, cash equivalents and short-term investments totaled $299.0 million at June 30, 2015, contrast to $135.8 million at December 31, 2014. Shares outstanding as of June 30, 2015 were 41.6 million.
Research and development expenses for the second quarter of 2015 were $18.6 million, contrast to $11.1 million for the comparable period in 2014. The enhance was primarily driven by enhances in personnel expenses and manufacturing activities.
Relypsa, Inc., a biopharmaceutical company, focuses on the development and commercialization of non-absorbed polymeric drugs to treat disorders in the areas of renal, cardiovascular, and metabolic diseases in the United States. Its lead product candidate comprises Patiromer, a non-absorbed potassium binding polymer that accomplished Phase III clinical trial for the treatment of hyperkalemia.
Euronav NV Ordinary Shares (NYSE:EURN), during its Monday’s current trading session decreased -1.39% to $14.16.
Euronav NV (EURN) stated its preliminary financial results for the three months ended 30 June 2015 and for the 6 months ended 30 June 2015.
All figures have been prepared under IFRS as adopted by the EU (International Financial Reporting Standards) and have not been audited nor reviewed by the statutory auditor.
*The number of shares outstanding on 30 June 2015 is 159,208,949.
For the second quarter 2015, the Company had a net result of USD 92.4 million or USD 0.58 per share (second quarter 2014: minus USD 22.6 million and minus USD 0.19 per share). EBITDA (a non-IFRS measure) for the same period was USD 142.3 million (second quarter 2014: USD 22.1 million).
Euronav has applied the accounting standards IFRS 10 and IFRS 11 as of 1 January 2014. If the Company would have continued to apply the proportionate consolidation method for its joint ventures for the first half of 2015, the adjusted EBITDA (a non-IFRS measure) would have been USD 316.1 million (first half 2014: USD 108.5 million) and the result after taxation would have remained the same.
Euronav NV, together with its auxiliaries, owns, operates, and manages a fleet of vessels for the transportation and storage of crude oil and petroleum products worldwide. The company operates through two segments: Tankers; and Floating Production, Storage, and Offloading/Floating, Storage, and Offloading (FPSO/FSO). As of April 27, 2015, it owned and operated a fleet of 53 double hulled vessels, counting 1 ultra large crude carrier; 2 floating, storage, and offloading (FSO) vessels; 27 very large crude carriers; and 23 suezmaxes.
Finally, ADTRAN, Inc. (NASDAQ:ADTN), gained 0.88%, to $16.09.
ADTRAN, Inc. (ADTN) declared that its Board of Directors has authorized the repurchase of an additional 5,000,000 shares of the Company’s common stock to commence upon completion of the repurchase plan declared May 19, 2014. There are 1,869,498 shares remaining to be repurchased under the May 2014 plan. Upon completion of the current plan, the new plan will be implemented through open market or private purchases from time to time as conditions warrant.
ADTRAN, Inc. is a leading global provider of networking and communications equipment. ADTRAN’s products enable voice, data, video and Internet communications across a variety of network infrastructures. ADTRAN solutions are presently in use by service providers, private enterprises, government organizations, and millions of individual users worldwide. For more information, please visit www.adtran.com.
ADTRAN, Inc. manufactures and sells networking and communications equipment worldwide. It operates in two divisions, Carrier Networks and Enterprise Networks. The Carrier Networks division provides broadband access products, such as multi-service access nodes, fiber to the nodes, digital subscriber line access multiplexer products, and distribution point units; optical products, counting optical networking edge, fiber Ethernet access devices, multi-service edge switches, multi-service provisioning platforms, and pluggable optical products; and time division multiplexed (TDM) systems under the Total Access and hiX brand names.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
